← Open Payments lookup

RACHEL MAYNARD: Open Payments

NPI 1093467052 · LOUISA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$951 in 51 payments from 10 companies in 2025. Trend: 2023 $734 · 2024 $1,022 · 2025 $951

Food & beverage: $880Education: $71
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.17$213
Vanda Pharmaceuticals Inc.8$167
Alkermes, Inc.8$151
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$143
Teva Pharmaceuticals USA, Inc.3$102
Neurocrine BioSciences, Inc.3$65
Janssen Pharmaceuticals, Inc2$39
Axsome Therapeutics, Inc.1$28
Lundbeck LLC1$25
E.R. Squibb & Sons, L.L.C.1$19

Products named: ARISTADA, CAPLYTA, REXULTI, ABILIFY ASIMTUFII, FANAPT, INGREZZA, HETLIOZ, INVEGA SUSTENNA.

Industry payments across KY — which companies pay providers there.